Title

Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications.

Document Type

Article

Publication Date

4-1-2018

Publication Title

Clin Diabetes

PubMed ID

29686454

Volume

36

Issue

2

First Page

149

Last Page

159

Share

COinS